نتایج جستجو برای: pharmacokinetic study

تعداد نتایج: 3982380  

Journal: :Bulletin of Pharmaceutical Sciences. Assiut 1993

Journal: :The Journal of pharmacology and experimental therapeutics 2000
C E Lau L Sun Q Wang A Simpao J L Falk

Despite wide use of cumulative-dosing procedures to evaluate dose-response relations, limited attention has been paid to investigating drug concentration-effect relations. We first characterized the pharmacokinetic (PK) parameters for i.v. (2 mg/kg) and oral cocaine (20 and 40 mg/kg) in rats. Cocaine's concentration-time profile for the escalating cumulative-dose regimen was simulated from PK p...

Journal: :Clinical pharmacology and therapeutics 2016
N Marsousi C F Samer P Fontana J L Reny S Rudaz J A Desmeules Y Daali

Ticagrelor is a potent antiplatelet drug metabolized by cytochrome (CYP)3A. It is contraindicated in patients with human immunodeficiency virus (HIV) because of the expected CYP3A inhibition by most protease inhibitors, such as ritonavir and an increased bleeding risk. In this study, a physiologically based pharmacokinetic (PBPK) model was created for ticagrelor and its active metabolite (AM). ...

Journal: :Journal of immunological methods 2008
Eugen Koren Holly W Smith Elizabeth Shores Gopi Shankar Deborah Finco-Kent Bonita Rup Yu-Chen Barrett Viswanath Devanarayan Boris Gorovits Shalini Gupta Thomas Parish Valerie Quarmby Michael Moxness Steven J Swanson Gary Taniguchi Linda A Zuckerman Christopher C Stebbins Anthony Mire-Sluis

The appropriate evaluation of the immunogenicity of biopharmaceuticals is of major importance for their successful development and licensure. Antibodies elicited by these products in many cases cause no detectable clinical effects in humans. However, antibodies to some therapeutic proteins have been shown to cause a variety of clinical consequences ranging from relatively mild to serious advers...

2017
Seth K. Amponsah George O. Adjei Christabel Enweronu-Laryea Kwasi A. Bugyei Kosta Hadji-Popovski Jorgen A.L. Kurtzhals Kim Kristensen

BACKGROUND Amikacin exhibits marked pharmacokinetic (PK) variability and is commonly used in combination with other drugs in the treatment of neonatal sepsis. There is a paucity of amikacin PK information in neonates from low-resource settings. OBJECTIVES To determine the PK parameters of amikacin, and explore the influence of selected covariates, including coadministration with aminophylline...

Journal: :Epilepsy & Behavior 2017
Alexander K. Berg Michael J. Myrvik Peter J. Van Ess

AIM Characterize pharmacokinetics, pharmacodynamics, and safety/tolerability of USL261 in geriatric adults to inform its potential for treating bouts of increased seizure activity. METHODS Phase 1, randomized, double-blind, 2-way crossover study in healthy geriatric (≥65years; n=18) and non-geriatric (18-40years; n=12) adults evaluated single USL261 doses (2.5 and 5.0mg) administered intranas...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016
Laurence Convert Réjean Lebel Suzanne Gascon Réjean Fontaine Jean-François Pratte Paul Charette Vincent Aimez Roger Lecomte

UNLABELLED Small-animal nuclear imaging modalities have become essential tools in the development process of new drugs, diagnostic procedures, and therapies. Quantification of metabolic or physiologic parameters is based on pharmacokinetic modeling of radiotracer biodistribution, which requires the blood input function in addition to tissue images. Such measurements are challenging in small ani...

Journal: :British journal of clinical pharmacology 2016
Nicole R Dobson Xiaoxi Liu Lawrence M Rhein Robert A Darnall Michael J Corwin Betty L McEntire Robert M Ward Laura P James Catherine M T Sherwin Timothy C Heeren Carl E Hunt

AIMS Caffeine concentrations in preterm infants are usually measured in the blood. However, salivary assays may provide a valid and practical alternative. The present study explored the validity and clinical utility of salivary caffeine concentrations as an alternative to blood concentrations and developed a novel plasma/salivary caffeine distribution model. METHODS Paired salivary and plasma...

2017
Ling Zhang Li Zhao Yonghong Liu Junfeng Liu Xianqiang Li

A comparative in vivo pharmacokinetic (PK) study of tilmicosin (TIL) was conducted in 6 crossbred healthy pigs and 6 crossbred pigs infected with Haemophilus (H.) parasuis following oral administration of a single 40 mg/kg dose. The infected model was established by intranasal inoculation and confirmed by clinical signs, blood biochemistry, and microscopic examinations. Plasma TIL concentration...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید